<?xml version="1.0" encoding="UTF-8"?>
<ref id="B23-molecules-25-04677">
 <label>23.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ajani</surname>
    <given-names>O.O.</given-names>
   </name>
   <name>
    <surname>Aderohunmu</surname>
    <given-names>D.V.</given-names>
   </name>
   <name>
    <surname>Ikpo</surname>
    <given-names>C.O.</given-names>
   </name>
   <name>
    <surname>Adedapo</surname>
    <given-names>A.E.</given-names>
   </name>
   <name>
    <surname>Olanrewaju</surname>
    <given-names>I.O.</given-names>
   </name>
  </person-group>
  <article-title>Functionalized Benzimidazole Scaffolds: Privileged Heterocycle for Drug Design in Therapeutic Medicine</article-title>
  <source>Arch. Pharm.</source>
  <year>2016</year>
  <volume>349</volume>
  <fpage>475</fpage>
  <lpage>506</lpage>
  <pub-id pub-id-type="doi">10.1002/ardp.201500464</pub-id>
  <?supplied-pmid 27213292?>
  <pub-id pub-id-type="pmid">27213292</pub-id>
 </element-citation>
</ref>
